TRPM5 rs886277 Polymorphism Predicts Hepatic Fibrosis Progression in Non-Cirrhotic HCV-Infected Patients.

Salvador Resino García Amanda Fernández-RodíguezDaniel Pineda-TenorAna Zaida Gómez-MorenoJuan José Sánchez-RuanoTomas Artaza-VarasaMaría José Muñoz-GómezAna Virseda-BerdicesMaría Martín-Vicente Isidoro MartínezMaría A Jiménez-Sousa

Published in: Journal of clinical medicine (2021)

TRPM5 rs886277 polymorphism was associated with liver fibrosis progression and cirrhosis development among hepatitis C virus (HCV)-infected patients. Specifically, the rs886277 C allele and CC genotype were risk factors for advancing liver fibrosis and cirrhosis compared to the rs886277 T allele and CT/TT genotype, respectively.

Keyphrases

liver fibrosis
hepatitis c virus
human immunodeficiency virus
computed tomography
image quality
dual energy
magnetic resonance imaging
positron emission tomography
magnetic resonance
hiv infected
antiretroviral therapy